CClinicalTrials.gg
Status unknownNCT04123912Updated Oct 11, 2019

Kinesio Taping and Physiotherapeutic Exercises for Children With DCD

An interventional study of Kinesio Taping - Functional Movement Power Training and Jogging with placebo taping in Developmental Coordination Disorder, sponsored by The University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2019-10-11.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

Aim: To investigate the effectiveness of a novel elastic taping-augmented functional movement power training (KT-FMPT) program in improving leg muscular performance, body balance, motor proficiency and functional independence in children with developmental coordination disorder (DCD).

Methodology: In this clinical trial, twenty children with DCD (aged 6-12) will be randomly assigned to either a KT-FMPT group or a placebo control group. Children in the KT-FMPT and control groups will receive elastic taping-augmented FMPT and general jogging exercise with non-elastic taping, respectively, for 12 weeks (2 hours/week). Major outcome measures: body balance and leg muscle activity will be measured via muscle sensors along with a force platform. Secondary outcome measures: leg muscle strength, motor proficiency and functional independence will be assessed by a digital dynamometer, the Movement Assessment Battery for Children-2 and Pediatric Evaluation of Disability Inventory, respectively (before- and after-intervention measurements).

Significance: The KT-FMPT group is predicted to display much better muscular and motor performances than the control group. This novel training program can be readily adopted in clinical, school, or home settings to improve functional independence in children with DCD, an outcome with positive socioeconomic implications. Moreover, study findings will inspire future research work in children with other childhood-onset disabilities.

02

Conditions studied

  • Developmental Coordination Disorder

Browse trials for

03

In context

Motor Skills Disorders

94 studies on the registry are indexed under Motor Skills Disorders; 24 are open to participants now.

This study's planned enrollment of 20 is below the median of 40 across 67 interventional studies indexed under Motor Skills Disorders.

Browse Motor Skills Disorders studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 6- to 12-years-old
  • classified as DCD according to the Diagnostic and Statistical Manual of Mental Disorders V
  • score \< 5th percentile on the Movement Assessment Battery for Children, 2nd edition (MABC-2)
  • total score \< 46 on the DCD questionnaire (2007)
  • attending a mainstream primary school with intelligence level within the normal range
  • no KT or FMPT experience

Exclusion criteria

Exclusion Criteria:

  • any known congenital, cognitive, psychiatric, neurological, sensorimotor, musculoskeletal or cardiopulmonary disorder that may affect test performance
  • receiving active rehabilitation treatment
  • demonstrating excessive disruptive behaviour
  • unable to follow instructions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    KT-FMPT group

    Behavioral: Kinesio Taping - Functional Movement Power Training

  • Placebo comparator
    Control group

    Behavioral: Jogging with placebo taping

Interventions

  • BehavioralKinesio Taping - Functional Movement Power Training

    Subjects assigned to the Kinesio Taping - Functional Movement Power Training (KT-FMPT) group will receive FMPT concurrent with KT. The FMPT protocol was developed by the research team with reference to common physiotherapeutic exercises for children with motor disabilities.9 It comprises 5 functional movement exercises and 6 lower-limb power/resistance training exercises using weights or resistance bands.

  • BehavioralJogging with placebo taping

    Subjects assigned to the control group will receive no FMPT or KT, but participate in a jogging intervention with placebo tape applied on their calf muscles and removed after the intervention.

06

What researchers measure

Primary outcomes

  1. Change in leg muscle electromyographic activation onset latency time (in ms)

    Electromyographic activation onset of leg muscles

    Time frame: 0 and 3 months

  2. Change in centre of pressure movement pathway in standing (in mm/cm)

    Centre of pressure movement pathway in standing

    Time frame: 0 and 3 months

Secondary outcomes

  1. Change in lower-extremity maximum isometric muscle strength (in kg/N)

    Maximum isometric leg muscle strength

    Time frame: 0 and 3 months

  2. Change in Movement Assessment Battery for Children-2 percentile score

    Movement Assessment Battery for Children-2 percentile (motor proficiency)

    Time frame: 0 and 3 months

  3. Change in Pediatric Evaluation of Disability Inventory score

    Pediatric Evaluation of Disability Inventory score (functional independence)

    Time frame: 0 and 3 months

07

Study locations

1 site
  • University of Hong Kong
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04123912
Lead sponsor
The University of Hong Kong
Responsible party
Shirley S.M. Fong (Dr, The University of Hong Kong) — Principal investigator
First posted
Oct 11, 2019
Start date
Jan 1, 2020 (estimated)
Primary completion
Dec 31, 2021 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Oct 11, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion